THE University of York’s tests on an anti-cancer drug which could eradicate previously untreatable cancers is going to clinical trials.

The Department of Chemistry has been investigating the medicinal properties of the platinum group of metals cancer curing properties.

One of these, termed RAPTA-C, showed promising activity on otherwise resistant tumours, with low toxicity. RAPTA-C is being promoted as a treatment for breast cancer after a spread to another organ. Currently, there is no real treatment, although some people respond to chemotherapy.

RAPTA-C also crosses the blood brain barrier, so could also be used to treat brain cancer, scientists said.